Page 2 - Division Of Blood News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Division of blood. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Division Of Blood Today - Breaking & Trending Today

Dr Frank on Sequencing Questions With CAR22 in Relapsed/Refractory LBCL

Matthew J. Frank, MD, PhD, discusses remaining questions regarding treatment sequencing following preliminary results from a phase 1 trial of a CD22-directed CAR-T therapy in relapsed/refractory large B-cell lymphoma.
....

Matthewj Frank , Division Of Blood , Stanford University , Stanford Health Care , Marrow Transplantation , Cellular Therapy , Cart Cell Therapy , Onclive Tv , Hematologic Oncology , Largeb Cell Lymphoma ,

CD22-Targeted CAR T Cells Elicit Responses With Acceptable Safety in Heavily Pretreated LBCL

Matthew Frank, MD, PhD, discusses the rationale for evaluating CD22 CAR T cells in heavily pretreated patients with large B-cell lymphoma, important safety and efficacy data with this approach, next steps for this research, and how continued efforts may shed needed light on sequencing in this space. ....

United States , Stanford University , Matthew Frank , Division Of Blood , Cellular Therapy At Stanford University , Stanford Health Care , National Cancer Institute , Marrow Transplantation , Cellular Therapy ,

Dr Frank on the Initial Efficacy and Safety of CAR22 in Relapsed/Refractory LBCL

Matthew Frank, MD, PhD, discusses preliminary results from a phase 1 trial of a CD22-directed CAR-T therapy in relapsed/refractory large B-cell lymphoma.

....

Matthew Frank , Division Of Blood , Stanford University , Marrow Transplantation , Cellular Therapy ,

Marker Therapeutics Appoints Monic Stuart, M.D., as Chief

Accomplished healthcare executive brings extensive drug development and regulatory experience from global pharmaceutical companies to Marker Therapeutics. ....

United States , Juanf Vera , Casey Mcdonald , Daniel Kontoh Boateng , Geron Corp , Stanford University , University Of North Carolina At Chapel Hill , Marrow Transplantation At Stanford University , Genentech Inc , Oncology Division , Head Of Clinical Development Or Advisor , Clinical Development At Geron Corporation , Marker Therapeutics Inc , Division Of Blood , Monic Stuart , Chief Medical , Marker Therapeutics , Chief Executive Officer , Chief Medical Officer , Clinical Development , Clinical Advisor , Vice President , Geron Corporation , Senior Medical Director , Marrow Transplantation , North Carolina ,

Educated Patient® Multiple Myeloma Summit On the Horizon Panel: April 8, 2023

Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit. ....

Kennethh Shain , Surbhi Sidana , Myeloma Research Foundation , Department Of Malignant Hematology , Myeloma Mentors Program , Molecular Medicine Program At Moffitt Cancer Center , Department Of Medicine , Patient Navigation Center , Malignant Hematology Program , Myeloma Management Panel , Division Of Blood , Brandonj Blue , Malignant Hematology , Moffitt Cancer Center , Marrow Transplantation , Cellular Therapy , Stanford University School , Tumor Biology , Chemical Biology , Molecular Medicine Program , Mary Derome , Multiple Myeloma Research , Myeloma Mentors , Bay Area , Facebook Lives ,